CD274 and breast carcinoma: The assessment of PD-L1 expression revealed: a) In most cases, there was no PD-L1 immunostaining in cancer and stromal cells, and b) among breast cancer subtypes, PD-L1 was mainly expressed by cancer and stromal cells in TNBC (Fig. 2b, c).